Belpointe Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.24M Buy
12,925
+1,976
+18% +$524K 0.2% 93
2026
Q1
$1.2M Sell
10,949
-7,207
-40% -$1.03M 0.04% 389
2025
Q4
$3.02M Buy
18,156
+7,537
+71% +$1.26M 0.11% 159
2025
Q3
$2.08M Sell
10,619
-17
-0.2% -$2.79K 0.08% 216
2025
Q2
$962K Buy
+10,636
New +$840K 0.04% 367

Other funds holding ALAB

Belpointe Asset Management's ALAB Position: Q2 2026 in Review

Belpointe Asset Management increased its Astera Labs (ALAB) stake by 18% in Q2 2026, buying an estimated $524K and bringing the position to 12,925 shares worth $6.24M. The position accounts for 0.2% of the portfolio, ranked #93.

Belpointe Asset Management first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Belpointe Asset Management held 12,925 shares of Astera Labs worth $6.24M as of Q2 2026.
  • Belpointe Asset Management bought 1,976 Astera Labs shares in Q2 2026, an estimated $524K.
  • Astera Labs made up 0.2% of Belpointe Asset Management's portfolio in Q2 2026, its #93 holding.
  • Belpointe Asset Management first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.